BR0311482A - Agente de transformação bacteriana - Google Patents
Agente de transformação bacterianaInfo
- Publication number
- BR0311482A BR0311482A BR0311482-1A BR0311482A BR0311482A BR 0311482 A BR0311482 A BR 0311482A BR 0311482 A BR0311482 A BR 0311482A BR 0311482 A BR0311482 A BR 0311482A
- Authority
- BR
- Brazil
- Prior art keywords
- bacterial strain
- unsubstituted
- agent
- substituted
- bacterial
- Prior art date
Links
- 230000010310 bacterial transformation Effects 0.000 title abstract 2
- 230000001580 bacterial effect Effects 0.000 abstract 5
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 125000005193 alkenylcarbonyloxy group Chemical group 0.000 abstract 2
- 125000003302 alkenyloxy group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000005198 alkynylcarbonyloxy group Chemical group 0.000 abstract 2
- 125000005133 alkynyloxy group Chemical group 0.000 abstract 2
- 239000004599 antimicrobial Substances 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 abstract 2
- 125000004104 aryloxy group Chemical group 0.000 abstract 2
- 210000002421 cell wall Anatomy 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000035945 sensitivity Effects 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 abstract 1
- 125000005225 alkynyloxycarbonyl group Chemical group 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 125000005199 aryl carbonyloxy group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
"AGENTE DE TRANSFORMAçãO BACTERIANA". Descreve-se um processo para aumentar a sensibilidade de uma cepa bacteriana a um agente antimicrobiano ativo contra parede celular, ao qual a cepa bacteriana ou uma cepa progenitora a partir da qual a cepa bacteriana tenha evoluído seja sensível. O processo compreende a etapa de exposição da cepa bacteriana ao agente de transformação com a seguinte fórmula (I): em que as frações R~ 1~ e R~ 2~ são, cada uma, independentemente selecionadas em alquila, alquilóxi, alquiloxicarbonila, alquilcarbonilóxi, alcenila, alcenilóxi, alceniloxicarbonila, alcenilcarbonilóxi, alcinila, alcinilóxi, alciniloxicarbonila, alcinilcarbonilóxi, cada uma podendo ser substituída ou não substituída, de cadeia linear ou ramificada ou cíclica, arila, arilóxi, ariloxicarbonila, arilcarbonilóxi, cada uma podendo ser substituída ou não substituída, e carbamoíla, a fração R~ 3~ é selecionada em alquila, alquilóxi, alquilcarbonilóxi, alcenila, alcenilóxi, alcenilcarbonilóxi, alcinila, alcinilóxi, alcinilcarbonilóxi, cada uma podendo ser substituída ou não substituída, de cadeia linear ou ramificada ou cíclica, arila, arilóxi, arilcarbonilóxi, cada uma podendo ser substituída ou não substituída, e carboxila, além disso, R~ 1~, R~ 2~ e R~ 3~ não são todos H, e Y é selecionado em uma cadeia colateral de aminoácido natural. Também se apresenta o uso de um agente com a fórmula acima na fabricação de um medicamento para aumentar a sensibilidade de uma cepa bacteriana que infecte, colonize ou esteja presente em um paciente a um agente antimicrobiano ativo contra parede celular.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0212622.5A GB0212622D0 (en) | 2002-05-31 | 2002-05-31 | Bacterial transforming agent |
| PCT/GB2003/002402 WO2003101488A1 (en) | 2002-05-31 | 2003-06-02 | Bacterial transforming agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0311482A true BR0311482A (pt) | 2005-03-15 |
Family
ID=9937806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0311482-1A BR0311482A (pt) | 2002-05-31 | 2003-06-02 | Agente de transformação bacteriana |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060040871A1 (pt) |
| EP (1) | EP1553981A1 (pt) |
| JP (1) | JP2006504404A (pt) |
| AU (1) | AU2003232352A1 (pt) |
| BR (1) | BR0311482A (pt) |
| CA (1) | CA2487597A1 (pt) |
| EA (1) | EA007093B1 (pt) |
| GB (1) | GB0212622D0 (pt) |
| IL (1) | IL165433A0 (pt) |
| MX (1) | MXPA04011879A (pt) |
| NO (1) | NO20045680L (pt) |
| NZ (1) | NZ537447A (pt) |
| WO (1) | WO2003101488A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009036121A1 (en) * | 2007-09-12 | 2009-03-19 | Targanta Therapeutics Corp. | Method of inhibiting clostridium difficile by administration of oritavancin |
| JP5947721B2 (ja) | 2009-10-30 | 2016-07-06 | アベラ ファーマスーティカルズ インコーポレイテッド | 変形性関節症を治療するためのジメチルスルホキシド（ｄｍｓｏ）およびメチルスルホニルメタン（ｍｓｍ）製剤 |
| ES2616630T3 (es) * | 2009-10-30 | 2017-06-13 | Biogenic Innovations, Llc | Uso de metilsulfonilmetano (MSM) para modular la actividad microbiana |
| DE102010013587A1 (de) * | 2010-03-31 | 2011-10-06 | Heliolux Gmbh | N-(Aminoacyl)-Amino-Ester |
| WO2012106469A2 (en) * | 2011-02-01 | 2012-08-09 | New York University | Methods for treating infections by targeting microbial h2s-producing enzymes |
| EP4147710A1 (en) | 2014-11-06 | 2023-03-15 | Xellia Pharmaceuticals ApS | Glycopeptide compositions in solution |
| WO2016201288A1 (en) * | 2015-06-12 | 2016-12-15 | Brown University | Novel antibacterial compounds and methods of making and using same |
| WO2018237268A1 (en) * | 2017-06-22 | 2018-12-27 | Brown University | NOVEL ANTIBACTERIAL COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF |
| US11555010B2 (en) | 2019-07-25 | 2023-01-17 | Brown University | Diamide antimicrobial agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5834430A (en) * | 1995-05-31 | 1998-11-10 | Biosynth S.R.L. | Potentiation of antibiotics |
| US6569830B1 (en) * | 1999-03-05 | 2003-05-27 | Ambi, Inc. | Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains |
-
2002
- 2002-05-31 GB GBGB0212622.5A patent/GB0212622D0/en not_active Ceased
-
2003
- 2003-06-02 JP JP2004508843A patent/JP2006504404A/ja not_active Withdrawn
- 2003-06-02 CA CA002487597A patent/CA2487597A1/en not_active Abandoned
- 2003-06-02 EP EP03756069A patent/EP1553981A1/en not_active Withdrawn
- 2003-06-02 IL IL16543303A patent/IL165433A0/xx unknown
- 2003-06-02 NZ NZ537447A patent/NZ537447A/en unknown
- 2003-06-02 AU AU2003232352A patent/AU2003232352A1/en not_active Abandoned
- 2003-06-02 BR BR0311482-1A patent/BR0311482A/pt not_active IP Right Cessation
- 2003-06-02 WO PCT/GB2003/002402 patent/WO2003101488A1/en active Application Filing
- 2003-06-02 US US10/517,359 patent/US20060040871A1/en not_active Abandoned
- 2003-06-02 EA EA200401589A patent/EA007093B1/ru unknown
- 2003-06-02 MX MXPA04011879A patent/MXPA04011879A/es unknown
-
2004
- 2004-12-28 NO NO20045680A patent/NO20045680L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20045680L (no) | 2005-02-28 |
| EA200401589A1 (ru) | 2005-06-30 |
| AU2003232352A1 (en) | 2003-12-19 |
| IL165433A0 (en) | 2006-01-15 |
| NZ537447A (en) | 2006-12-22 |
| MXPA04011879A (es) | 2005-09-12 |
| WO2003101488A1 (en) | 2003-12-11 |
| EP1553981A1 (en) | 2005-07-20 |
| EA007093B1 (ru) | 2006-06-30 |
| US20060040871A1 (en) | 2006-02-23 |
| JP2006504404A (ja) | 2006-02-09 |
| CA2487597A1 (en) | 2003-12-11 |
| GB0212622D0 (en) | 2002-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2176502T3 (es) | Derivados de hidroxilamina utiles para mejorar la pproduccion de chaperonas moleculares su su preparacion. | |
| CA2288445A1 (en) | 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives | |
| NO20042596L (no) | Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1 | |
| MXPA04004842A (es) | Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1. | |
| BR0317891A (pt) | Tratamento de ferimentos de pele usando polienilfosfatidil colina e alcanolaminas | |
| SE0001899D0 (sv) | New compounds | |
| BR9916790A (pt) | Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente | |
| BR9916781A (pt) | 4-oxo-1,4-dihidro-3-quinolinacarboxamidas comoagentes antivirais | |
| HUP9702345A2 (hu) | 3-Hidroxi-piridin-2-karbonsav-amid-észter-származékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| BR0312464A (pt) | Inibidores de tirosina quinases | |
| BR0010716A (pt) | Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas | |
| BR0311482A (pt) | Agente de transformação bacteriana | |
| RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| BRPI0414979A (pt) | preparação sólida | |
| UA93529C2 (ru) | Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами | |
| RS44304A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| NO20053876D0 (no) | Karbonylaminosubstituerte acylfenylurederivater, fremgangsmate for deres fremstilling samt anvendelse derav | |
| BR0213550A (pt) | Composição anti-helmìntica | |
| BR0112338A (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| HUP0105359A2 (hu) | Benzamidszármazékok és az azokat tartalmazó gyógyszerkészítmények | |
| EA199900510A1 (ru) | Инъекционное лекарственное средство "цитофлавин", обладающее цитопротекторным действием | |
| DE60006379D1 (de) | Vitamin d-analogen und ihre pharmazeutische verwendung | |
| DE69615657T2 (de) | Antifungal fusacandine | |
| EA200400709A1 (ru) | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 | |
| BR0213463A (pt) | Composições farmacêuticas contendo macrólidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A,6A E 7A ANUIDADES |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2064 DE 27/07/2010. |